Valuation : Medicure Inc.

Market Cap 26.09M 18.89M 16.25M 15.28M 13.95M 1.79B 26.18M 181M 70.04M 915M 70.95M 69.4M 2.91B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 23.15M 16.76M 14.42M 13.56M 12.38M 1.59B 23.22M 161M 62.14M 812M 62.95M 61.57M 2.59B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day+2.04%
Current month-1.96%
1 month+92.31%
3 months+131.48%
6 months+157.73%
Current year+119.30%
1 week 2.45
Extreme 2.45
2.6
1 month 1.28
Extreme 1.28
2.6
Current year 0.85
Extreme 0.85
2.6
1 year 0.85
Extreme 0.85
2.6
3 years 0.63
Extreme 0.63
2.6
5 years 0.63
Extreme 0.63
2.6
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 14/09/1997
Director of Finance/CFO 48 14/07/2011
Chief Tech/Sci/R&D Officer - 30/06/2019
Director TitleAgeSince
Chairman 79 14/09/1997
Director/Board Member 93 27/02/2000
Director/Board Member 56 21/01/2013
Date Insider Type Main position Quantity % Market Cap. Importance
30/07/26 Option

Chief Technology Officer

-20,000 0.1916%
28/03/25 Option

Chief Technology Officer

7,500 0.0719%
28/03/25 Option

Director

7,200 0.0690%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%0.00%+123.21%+74.83% 18.86M
-0.38%-2.64%+42.69%+99.03% 67.98B
-2.71%-0.71%+34.08%+81.43% 64.94B
-0.31%+6.54%-12.96%+377.83% 27.58B
+0.86%+1.65%-7.74%-13.58% 26.06B
-1.42%-4.28%+31.24%+13.27% 25.74B
-1.11%+0.90%+23.12%-18.50% 20.09B
+1.15%-14.24%+219.82%+381.14% 17.16B
+0.20%-4.68%-6.41%+560.92% 14.92B
-0.20%+8.37%+55.78%+165.57% 14.62B
Average -0.19%+0.94%+50.28%+172.19% 27.91B
Weighted average by Cap. -0.81%+0.59%+36.97%+141.11%

Financials

2024 2025
Net sales 21.91M 15.86M 13.64M 12.83M 11.71M 1.5B 21.98M 152M 58.81M 768M 59.58M 58.27M 2.45B 28.86M 20.9M 17.97M 16.9M 15.43M 1.98B 28.95M 200M 77.46M 1.01B 78.47M 76.75M 3.22B
Net income -1.04M -752K -647K -609K -556K -71.16M -1.04M -7.22M -2.79M -36.44M -2.83M -2.76M -116M -7.1M -5.14M -4.42M -4.16M -3.79M -486M -7.12M -49.29M -19.05M -249M -19.3M -18.88M -793M
Net Debt -6.32M -4.57M -3.93M -3.7M -3.38M -433M -6.34M -43.87M -16.96M -222M -17.18M -16.8M -706M -2.94M -2.13M -1.83M -1.72M -1.57M -202M -2.95M -20.45M -7.9M -103M -8.01M -7.83M -329M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
04/09/26 CA$2.500 +2.04% 304
03/09/26 CA$2.450 -4.67% 2,811
02/09/26 CA$2.570 +0.39% 1,300
01/09/26 CA$2.560 +0.39% 1,000
31/08/26 CA$2.550 +2.00% 10,238
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!